Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.86−0.06 (-0.73%)
Close on Nov 17, 2026Market cap $3.00BP/E –Yield –
Telix Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Telix Pharmaceuticals's price to sales ratio was 4.1× on Nov 11, 2026, against 6.6× a year earlier. Over the last 2 years it ranged from 3.8× to 18.1×, with a median of 6.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | −0.9 |
| 2025 | Dec 31, 2025 | 5.0× | −10.0 |
| 2024 | Dec 31, 2024 | 15.0× | – |
See a number that looks wrong?